Genetic stability of human T lymphotropic virus type I despite antiviral pressures by CTLs

Journal of Immunology

Volumn 178, Issue 9, 2007, Pages 5966-5972

  Kubota, Ryuji ^a   Hanada, Kousuke ^b   Furukawa, Yoshitaka ^a   Arimura, Kimiyoshi ^a   Osame, Mitsuhiro ^a   Gojobori, Takashi ^b   Izumo, Shuji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF GENETICS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A2 ANTIGEN; REGULATOR PROTEIN; TAX PROTEIN; VACCINE;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; DRUG TARGETING; GENE SEQUENCE; GENETIC STABILITY; GENOTYPE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; IN VIVO STUDY; INFLAMMATORY DISEASE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; T LYMPHOCYTE; TAX GENE; VIRUS GENE; VIRUS LOAD; VIRUS REPLICATION;

EID: 34247590187     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.9.5966     Document Type: Article

References (36)

1. Uchiyama, T., J. Yodoi, K. Sagawa, K. Takatsuki, and H. Uchino. 1977. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50: 481-492.
2. Osame, M., K. Usuku, S. Izumo, N. Ijichi, H. Amitani, A. Igata, M. Matsumoto, and M. Tara. 1986. HTLV-I associated myelopathy, a new clinical entity. Lancet 1: 1031-1032.
3. Umehara, F., S. Izumo, M. Nakagawa, A. T. Ronquillo, K. Takahashi, K. Matsumuro, E. Sato, and M. Osame. 1993. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J. Neuropathol. Exp. Neurol. 52: 424-430.
4. Osame, M., M. Matsumoto, K. Usuku, S. Izumo, N. Ijichi, H. Amitani, M. Tara, and A. Igata. 1987. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann. Neurol. 21: 117-122.
5. Nagai, M., K. Usuku, W. Matsumoto, D. Kodama, N. Takenouchi, T. Moritoyo, S. Hashiguchi, M. Ichinose, C. R. Bangham, S. Izumo, and M. Osame. 1998. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J. Neurovirol. 4: 586-593.
6. Takenouchi, N., Y. Yamano, K. Usuku, M. Osame, and S. Izumo. 2003. Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy/ tropical spastic paraparesis. J. Neurovirol. 9: 29-35.
7. + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348: 245-248.
8. + cytotoxic T cells directed against HTLV-I-infected cells. Int. Immunol. 3: 761-767.
9. Parker, C. E., S. Daenke, S. Nightingale, and C. R. Bangham. 1992. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 188: 628-636.
10. + T-cell epitopes by acquisition of peptide-HLA-GFP complexes: analysis of T-cell phenotype and function in chronic viral infections. Nat. Med. 9: 469-476.
11. Nei, M., and T. Gojobori. 1986. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3: 418-426.
12. Niewiesk, S., S. Daenke, C. E. Parker, G. Taylor, J. Weber, S. Nightingale, and C. R. Bangham. 1994. The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J. Virol. 68: 6778-6781.
13. Zinkernagel, R. M., and P. C. Doherty. 1974. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248: 701-702.
14. Phillips, R. E., S. Rowland-Jones, D. F. Nixon, F. M. Gotch, J. P. Edwards, A. O. Ogunlesi, J. G. Elvin, J. A. Rothbard, C. R. Bangham, C. R. Rizza, et al. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354: 453-459.
15. Borrow, P., H. Lewicki, X. Wei, M. S. Horwitz, N. Peffer, H. Meyers, J. A. Nelson, J. E. Gairin, B. H. Hahn, M. B. Oldstone, and G. M. Shaw. 1997. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3: 205-211.
16. Evans, D. T., D. H. O'Connor, P. Jing, J. L. Dzuris, J. Sidney, J. da Silva, T. M. Allen, H. Horton, J. E. Venham, R. A. Rudersdorf, et al. 1999. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat. Med. 5: 1270-1276.
17. + T cells during viral replication in patients with HTLV-1-associated myelopathy (HAM/TSP). Blood 101: 3074-3081.
18. Parker, C. E., S. Nightingale, G. P. Taylor, J. Weber, and C. R. Bangham. 1994. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. J. Virol. 68: 2860-2868.
19. Daenke, S., A. G. Kermode, S. E. Hall, G. Taylor, J. Weber, S. Nightingale, and C. R. Bangham. 1996. High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis. Virology 217: 139-146.
20. Koenig, S., R. M. Woods, Y. A. Brewah, A. J. Newell, G. M. Jones, E. Boone, J. W. Adelsberger, M. W. Baseler, S. M. Robinson, and S. Jacobson. 1993. Characterization of MHC class 1 restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease. J. Immunol. 151: 3874-3883.
21. Pique, C., F. Connan, J. P. Levilain, J. Choppin, and M. C. Dokhelar. 1996. Among all human T-cell leukemia virus type 1 proteins, tax, polymerase, and envelope proteins are predicted as preferential targets for the HLA-A2-restricted cytotoxic T-cell response. J. Virol. 70: 4919-4926.
22. Felsenstein, J. 1981. Evolutionary trees from DNA sequences: a maximum likelihood approach. J. Mol. Evol. 17: 368-376.
23. Hartigan, J. A. 1973. Minimum evolution fits to a given tree. Biometrics 29: 53-65.
24. Zhang, J., S. Kumar, and M. Nei. 1997. Small-sample tests of episodic adaptive evolution: a case study of primate lysozymes. Mol. Biol. Evol. 14: 1335-1338.
25. Suzuki, Y., and T. Gojobori. 1999. A method for detecting positive selection at single amino acid sites. Mol. Biol. Evol. 16: 1315-1328.
26. Suzuki, Y., T. Gojobori, and M. Nei. 2001. ADAPTSITE: detecting natural selection at single amino acid sites. Bioinformatics 17: 660-661.
27. Utz, U., S. Koenig, J. E. Coligan, and W. E. Biddison. 1992. Presentation of three different viral peptides, HTLV-1 Tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule. J. Immunol. 149: 214-221.
28. Seiki, M., S. Hattori, Y. Hirayama, and M. Yoshida. 1983. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc. Natl. Acad. Sci. USA 80: 3618-3622.
29. Kannagi, M., H. Shida, H. Igarashi, K. Kuruma, H. Murai, Y. Aono, I. Maruyama, M. Osame, T. Hattori, H. Inoko, et al. 1992. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J. Virol. 66: 2928-2933.
30. Niewiesk, S., S. Daenke, C. E. Parker, G. Taylor, J. Weber, S. Nightingale, and C. R. Bangham. 1995. Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax. J. Virol. 69: 2649-2653.
31. Yoshida, M., J. Inoue, J. Fujisawa, and M. Seiki. 1989. Molecular mechanisms of regulation of HTLV-1 gene expression and its association with leukemogenesis. Genome 31: 662-667.
32. Smith, M. R., and W. C. Greene. 1990. Identification of HTLV-I tax transactivator mutants exhibiting novel transcriptional phenotypes. Genes Dev. 4: 1875-1885.
33. Friedrich, T. C., E. J. Dodds, L. J. Yant, L. Vojnov, R. Rudersdorf, C. Cullen, D. T. Evans, R. C. Desrosiers, B. R. Mothe, J. Sidney, et al. 2004. Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat. Med. 10: 275-281.
34. Leslie, A. J., K. J. Pfafferott, P. Chetty, R. Draenert, M. M. Addo, M. Feeney, Y. Tang, E. C. Holmes, T. Allen, J. G. Prado, et al. 2004. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 10: 282-289.
35. Hanada, K., Y. Suzuki, and T. Gojobori. 2004. A large variation in the rates of synonymous substitution for RNA viruses and its relationship to a diversity of viral infection and transmission modes. Mol. Biol. Evol. 21: 1074-1080.
36. Wattel, E., J. P. Vartanian, C. Pannetier, and S. Wain-Hobson. 1995. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J. Virol. 69: 2863-2868.